1. Neutralizing Effect of Synthetic Peptides toward SARS-CoV-2
- Author
-
Pedro F.N. Souza, Maurício F. vanTilburg, Felipe P. Mesquita, Jackson L. Amaral, Luina B. Lima, Raquel C. Montenegro, Francisco E.S. Lopes, Rafael X. Martins, Leonardo Vieira, Davi F. Farias, Ana C. O. Monteiro-Moreira, Cleverson D.T. Freitas, Arnaldo S. Bezerra, Maria I. F. Guedes, Débora S.C.M. Castelo-Branco, and Jose T.A. Oliveira
- Subjects
General Chemical Engineering ,General Chemistry - Abstract
The outbreak caused by SARS-CoV-2 has taken many lives worldwide. Although vaccination has started, the development of drugs to either alleviate or abolish symptoms of COVID-19 is still necessary. Here, four synthetic peptides were assayed regarding their ability to protect Vero E6 cells from SARS-CoV-2 infection and their toxicity to human cells and zebrafish embryos. All peptides had some ability to protect cells from infection by SARS-CoV-2 with the D614G mutation. Molecular docking predicted the ability of all peptides to interact with and induce conformational alterations in the spike protein containing the D614G mutation. PepKAA was the most effective peptide, by having the highest docking score regarding the spike protein and reducing the SARS-CoV-2 plaque number by 50% (EC
- Published
- 2022